Sarepta Therapeutics (SRPT) PT Lowered to $187 at RBC Capital
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $17.53 +3.36%
Rating Summary:
18 Buy, 19 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Rating Summary:
18 Buy, 19 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
RBC Capital lowered its price target on Sarepta Therapeutics (NASDAQ: SRPT) to $187.00 (from $189.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sarepta Therapeutics (SRPT) 5700 contracts of July 20 calls trade
- Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
- PolyPeptide Group AG (PPGN:SW) PT Raised to CHF45 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
